Cancer Biomarker Market Size, Share & Trends Analysis Report By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1. Methodology and Scope
1.1.信息Procurement
1.1.1. Purchased database:
1.1.2. GVR’s internal database
1.2. Research Methodology
1.3. Geographic Scope & Assumptions
1.4. Region-wise Market Calculation
1.4.1. Region-wise market: Base estimates
1.4.2. Global market: CAGR calculation
1.5. Region-based Segment Share Calculation
1.6. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Cancer Biomarkers Industry Outlook
3.1. Market Segmentation & Scope
3.1.1. Market driver analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of cancer
3.1.1.3 Increasing government funding for cancer research
3.1.1.4 Technological advancements
3.1.2. Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.2. Penetration & Growth Prospect Mapping
3.3. Cancer biomarkers - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4. Industry Analysis - Porter’s
Chapter 4. Cancer Biomarkers Market: Type Outlook
4.1. Cancer biomarkers market share by type, movement analysis
4.2. Breast cancer
4.2.1. Breast cancer Market estimates and forecast, 2014 - 2025 (USD Billion)
4.4. Prostate Cancer
4.4.1. Prostate cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.5. Colorectal Cancer
4.5.1. Colorectal cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.6. Cervical Cancer
4.6.1. Cervical cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.7. Liver Cancer
4.7.1. Liver cancer market estimates and forecast, 2014 - 2025 (USD Billion)
4.8. Lung Cancer
4.8.1.肺癌市场估计和预测,2014 - 2025 (USD Billion)
4.9. Others
4.9.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)
Chapter 5. Cancer biomarkers Market: Biomolecule Estimates & Trend Analysis
5.1. Cancer Biomarkers Market: Biomolecule Movement Analysis
5.2. Genetic Biomarkers
5.2.1. Genetic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.3. Epigenetic Biomarkers
5.3.1. Epigenetic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.4. Metabolic Biomarkers
5.4.1. Metabolic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.5. Proteomic Biomarkers
5.5.1. Proteomic biomarkers market estimates and forecast, 2014 - 2025 (USD Billion)
5.6. Others
5.6.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)
Chapter 6. Cancer biomarkers Market: Application Estimates & Trend Analysis
6.1. Cancer Biomarkers Market: Application Movement Analysis
6.2. Drug Discovery
6.2.1. Drug discovery market estimates and forecast, 2014 - 2025 (USD Billion)
6.3. Diagnostics
6.3.1. Diagnostics market estimates and forecast, 2014 - 2025 (USD Billion)
6.4. Personalized Medicine
6.4.1. Personalized medicine market estimates and forecast, 2014 - 2025 (USD Billion)
6.5. Others
6.5.1. Others market estimates and forecast, 2014 - 2025 (USD Billion)
Chapter 7. Cancer Biomarkers Market: Regional Outlook
7.1. Cancer biomarkers market share by region, 2015 & 2025 (USD Billion)
7.2. North America
7.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.2.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.2.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.2.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.2.2. U.S.
7.2.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.2.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.2.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.2.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.2.3. Canada
7.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.2.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.2.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.2.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.3. Europe
7.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.3.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.3.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.3.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.3.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.3.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.3.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.3.3. UK
7.3.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.3.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.3.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.3.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4.2. China
7.4.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4.3. India
7.4.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.4.4. Japan
7.4.4.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.4.4.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.4.4.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.4.4.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.5. Latin America
7.5.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.5.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.5.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.5.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.5.2. Brazil
7.5.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.5.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.5.2.3.产品市场的估计和预测biomolecule, 2014 - 2025 (USD Billion)
7.5.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.5.3. Mexico
7.5.3.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.5.3.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.5.3.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.5.3.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.6.1.1. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.6.1.2. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.6.1.3. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
7.6.2. South Africa
7.6.2.1. Market estimates and forecast, 2014 - 2025 (USD Billion)
7.6.2.2. Market estimates and forecast by type, 2014 - 2025 (USD Billion)
7.6.2.3. Product market estimates and forecast by biomolecule, 2014 - 2025 (USD Billion)
7.6.2.4. Market estimates and forecast by application, 2014 - 2025 (USD Billion)
Chapter 8. Company Profiles
8.1. Strategy Framework
8.2. Market Participation Categorization
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. 9F. Hoffmann-La Roche Ltd
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Qiagen N.V
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Affymetrix Inc
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Illumina, Inc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Agilent Technologies
8.3.6.1. Company overview
8.3.6.2. Financial overview
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Merck & Co. Inc
8.3.7.1. Company overview
8.3.7.2. Financial overview
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Hologic, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial overview
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Sino Biological Inc.
8.3.9.1. Company overview
8.3.9.2. Financial overview
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Thermo Fisher Scientific Inc.
8.3.10.1. Company overview
8.3.10.2. Financial overview
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Becton, Dickinson and Company
8.3.11.1. Company overview
8.3.11.2. Financial overview
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 3 North America cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 4 North America cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 5 U.S. cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 6 U.S. cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 7 U.S. cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 8 Canada cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 9 Canada cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 10 Canada cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 11 Europe cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 12 Europe cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 13 Europe cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 14 UK cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 15 UK cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
表16英国癌症生物标记物市场估计forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 17 Germany cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 18 Germany cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 19 Germany cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 20 Asia Pacific cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 21 Asia Pacific cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 22 Asia Pacific cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 23 Japan cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 24 Japan cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 25 Japan cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 26 China cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 27 China cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 28 China cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 29 India cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 30 India cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 31 India cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 32 Latin America cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 33 Latin America cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 34 Latin America cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 35 Brazil cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 36 Brazil cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 37 Brazil cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 38 Mexico cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 39 Mexico cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 40 Mexico cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 41 MEA cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 42 MEA cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 43 MEA cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 44 South Africa cancer biomarkers market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 45 South Africa cancer biomarkers market estimates and forecasts, by biomolecule, 2014 - 2025 (USD Billion)
TABLE 46 South Africa cancer biomarkers market estimates and forecasts, by application, 2014 - 2025 (USD Billion)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends &outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Global percentage of population, by age group, 2050 and 2000
FIG. 10 Market restraint relevance analysis (Current & future impact)
FIG. 11 Penetration & growth prospect mapping
FIG. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Cancer biomarkers market type outlook key takeaways
FIG. 15 Cancer biomarkers market: Type movement analysis
FIG. 16 Global breast cancer market, 2014 - 2025 (USD Billion)
FIG. 17 Global prostate cancer market, 2014 - 2025 (USD Billion)
FIG. 18 Global colorectal cancer market, 2014 - 2025 (USD Billion)
FIG. 19 Global cervical cancer market, 2014 - 2025 (USD Billion)
FIG. 20 Global liver cancer market, 2014 - 2025 (USD Billion)
FIG. 21 Global lung cancer market, 2014 - 2025 (USD Billion)
FIG. 22 Global other cancer market, 2014 - 2025 (USD Billion)
FIG. 23 Cancer biomarkers market biomolecule outlook key takeaways
FIG. 24 Cancer biomarkers market: Biomolecule movement analysis
FIG. 25 Global genetic biomarkers market, 2014 - 2025 (USD Billion)
FIG. 26 Global epigenetic biomarkers market, 2014 - 2025 (USD Billion)
FIG. 27 Global metabolic biomarkers market, 2014 - 2025 (USD Billion)
FIG. 28 Global proteomic biomarkers market, 2014 - 2025 (USD Billion)
FIG. 29 Global other biomarkers market, 2014 - 2025 (USD Billion)
FIG. 30 Cancer biomarkers market application outlook key takeaways
FIG. 31 Cancer biomarkers market: Application movement analysis
FIG. 32 Drug discovery market, 2014 - 2025 (USD Billion)
FIG. 33 Diagnostics market, 2014 - 2025 (USD Billion)
FIG. 34 Personalized medicine market, 2014 - 2025 (USD Billion)
FIG. 35 Others market, 2014 - 2025 (USD Billion)
FIG. 36 Regional market place: Key takeaways
FIG. 37 Regional outlook, 2015 & 2025
FIG. 38 North America Cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 39 U.S. cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 40 Canada cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 41 Europe cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 42 UK cancer biomarkers market, 2014 - 2025 (USD Billion)
图43德国癌症生物标记物的市场,2014 - 2025 (USD Billion)
FIG. 44 Asia Pacific cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 45 Japan cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 46 China cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 47 India cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 48 Latin America cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 49 Brazil cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 50 Mexico cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 51 MEA cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 52 South Africa cancer biomarkers market, 2014 - 2025 (USD Billion)
FIG. 53 Strategy framework
FIG. 54 Participant categorization